I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the recent developments surrounding Agios Pharmaceuticals and their
In a groundbreaking development for rheumatoid arthritis treatment, Lifordi Immunotherapeutics, a clinical-stage biotech firm headquartered in Burlington, Massachusetts, has successfully raised $112 million in a funding round led by Sanofi Ventures, with continued support from prominent investors
In a world where humanity faces pressing challenges like sustainable energy and life-threatening diseases, the emergence of artificial intelligence as a collaborative partner in scientific discovery offers a beacon of hope. Imagine a future where complex experiments that once took decades are
In a world where medical advancements have conquered countless diseases, a silent yet deadly threat looms large—drug-resistant fungal infections are claiming millions of lives each year, often with little public attention. These infections strike hardest at the most vulnerable, such as cancer
Could a tiny, often overlooked component of the immune system hold the answer to saving the pork industry from a billion-dollar scourge? Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) devastates pig herds worldwide, slashing productivity and straining farm economies with staggering
In a groundbreaking moment for the biotechnology sector, San Diego-based startup Iambic has captured the spotlight by raising an impressive $100 million in Series B financing to propel clinical trials of its AI-discovered cancer drugs, marking a significant milestone for the company. This
